Table of Contents Table of Contents
Previous Page  239 / 1224 Next Page
Information
Show Menu
Previous Page 239 / 1224 Next Page
Page Background

GBM

HNC

RT +/- concurrent cisplatin

RT +/- concurrent temozolomide

30 x 2Gy

30 x 2Gy

5 x 6Gy

5 x 6Gy

Ohri et al: IJROBP 2012; 83 (1): 385